Objective: The aims of this study were to describe the computed tomographic features of organizing pneumonia (OP) in an oncologic patient population and to also identify features associated with lung cancer and patients undergoing hematopoietic stem cell transplant (HSCT).
O rganizing pneumonia (OP) is a pulmonary response to injury, demonstrating inflammatory intra-alveolar infiltrates on pathology. 1 It can occur in association with a number of conditions, for example, infection, drug reactions, bone marrow/organ transplantation, and radiation therapy. 2 Many of these conditions are commonly encountered in an oncologic population, and so, an awareness of the radiologic features of OP is important to avoid misdiagnosing OP as a malignancy. When OP occurs as a primary entity with no known causation, it is then referred to as cryptogenic OP. The histological evaluation of OP typically reveals polypoid plugs of the granulation tissue filling the alveoli and small airways (Masson bodies). 2, 3 These inflammatory tissue plugs occlude the distal bronchioles, thus giving OP the previously used term bronchiolitis obliterans OP. 4 The radiographic appearance of OP is typically described as bilateral patchy airspace opacities-often in a subpleural or peribronchial distribution. In 1989, Cordier et al 5 originally described 3 main imaging patterns of OP: multiple alveolar opacities, solitary opacity, and infiltrative opacities. Since then, others in the literature have described other imaging features such as ground glass opacities (GGOs), consolidation with air bronchograms, small nodular or linear ill-defined opacities, bronchial wall thickening, and larger nodules or masses. Pleural effusions, although less commonly described in OP, have been reported in up to 22% of cases in 1 case series. 6, 7 These studies, conducted previously to evaluate the imaging appearances of OP, have often been limited by small numbers of patients. The largest series to date was composed of only 45 patients. 1 Moreover, no previous study has evaluated the computed tomographic (CT) appearances of OP in an oncologic patient population. The goals of this study then were to describe the CT features of OP in an oncologic patient population and to also identify any CT features associated with OP in lung cancer and undergoing hematopoietic stem cell transplant (HSCT).
MATERIALS AND METHODS

Patient Cohort
This retrospective study received a waiver of consent from our institutional review board. With the waiver in place, we searched the pathology patient database from January 2, 2009, to September 4, 2014, for "organizing pneumonia" and patients who had a chest CT performed within the previous 2 weeks of the pathology report. This yielded 250 unique consecutive patients, of which 99 patients were excluded for the following reasons: no history of malignancy (16 patients), no diagnosis of OP (14 patients), biopsy not performed within the 2 weeks of the pathology report (2 patients), OP found on autopsy reports (6 patients), and microscopic OP incidentally found without CT correlate (61 patients). One hundred fifty-one remaining patients were submitted for analysis.
Image Analysis
To ensure a baseline consensus on the lexicon used for data collection, a training session was held. Sample cases were reviewed by the 2 reading radiologists (N.L. and R.S.), who were oncologic imaging fellows, and 2 dedicated chest radiologists (A.P. and M.G.), who had 2 and 19 years posttraining experience, respectively. After having established baseline consensus, each patient's CT was reviewed by 1 of 2 reading radiologists (N.L. and R.S.). The reading radiologist identified all patients who did not fit the terminology clearly; in such an event, the CT was subsequently reviewed in consensus with the senior radiologist (M.G.). All images were reviewed on the institutional Picture Archiving and Communication System (GE Centricity RA100). The imaging protocol for each CT varied given that a number of patients had imaging from outside the institution. Five-millimeter slice images were available for review in all patients with additional thin slice images (1.25 mm) available in 26 patients (17%). Intravenous contrast was administered in 67 patients (44%).
Characteristics of the Lesion
The size of the lesion was measured on lung windows by selecting the longest measurement (length) and the greatest perpendicular distance (width) on the same slice. The location of the lesion was determined to be central if the lesion contacted a bronchus to the lobar level and peripheral if the lesion contacted a segmental bronchus or smaller. A lesion bordering the two was classified as both peripheral and central in location. In the case of multiple lesions, the characteristics of the largest lesion were recorded.
The contour of the lesion was recorded as round (sphere with clearly defined smooth margins), lobulated (not spherical but with clearly defined smooth margins), spiculated (solid lesion with linear extensions into the adjacent lung parenchyma), or ill-defined (nondefinable borders). The number of lesions was recorded as follows: solitary, 1 to 5, 6 to 10, or greater than 10. In the cases where definable lesion/s were not present but had an appearance similar to pneumonia, the number was recorded as diffuse. The consistency of the lesion was recorded as solid (density obscures the underlying pulmonary vessels and parenchyma), ground glass (increased attenuation of the lung parenchyma with preserved visualization of the underlying pulmonary vessels), or consisting of air bronchograms (persistent visualization of the bronchi with surrounding increased attenuation). Additional characteristics of surrounding GGO, cavitation (pockets of air within the lesion), and necrosis (central low attenuation with peripheral enhancement) were also recorded.
Ancillary Features
Ancillary features of the lesion that were recorded were the presence of lymphadenopathy and volume (nodes with a short axis measurement of between ≥10 and <15, ≥15 and <30, or ≥30 mm), pleural effusion size (small, moderate, or large), and laterality.
Statistical Analysis
Fisher exact test was used to compare categorical features in patients with (1) lung cancer with other malignancies and (2) patients post-HSCT with those who did not receive HSCT. The Wilcoxon rank-sum test was used to compare age and baseline size between groups.
A test with a P value less than 0.05 was considered statistically significant. All statistical analyses were performed in software packages SAS 9.4 (SAS Institute Inc, Cary, NC).
RESULTS
Computed tomography features of pathologically confirmed OP were examined in 151 patients, all of whom had a history of malignancy. The median patient age was 61 (range, 9-91)years with a similar sex breakdown (female, 48%; male, 52%). The most common malignancies were leukemia (n = 36), lymphoma (n = 29), lung cancer (n = 25), and breast cancer (n = 13; Table 1 ). There were 29 patients with a history of HSCT. The lesions ranged in size from 4 to 79 mm (mean, 25.1 mm; median, 22 mm). Table 2 summarizes the imaging characteristics of OP. In all patients, 41% had diffuse presentation without definable lesions (Fig. 1) , which was more common than lesions presenting as either solitary or multiple lesions (Fig. 2) . Organizing pneumonia presented as a solitary lesion in 21% of patients, as 1 to 5 lesions in 21%, as 6 to 10 lesions in 9%, and as greater than 10 lesions in 9%.
Lesions were most commonly seen in both peripheral and central in location (53%) (Fig. 3) . Forty-four percent of lesions were located peripherally, with only 3% of lesions seen in a central location. The most common lobe involved was the right lower lobe (72%). Lesions of OP most commonly presented with an ill-defined margin (52%). A spiculated border was present in 23%, and a lobular or smooth border was observed in 14% and 11% of patients, respectively.
The consistency of the lesion was predominantly solid (44%) or containing some internal ground glass attenuation (53%) (Fig. 4) . Air bronchograms were found in 27% of OP lesions, and GGO in the surrounding parenchyma was seen with 22% of cases.
Adjacent bronchiectasis, cavitation, and internal necrosis were rarely associated with lesions of OP (3%, 6%, and 1%, respectively). Lymphadenopathy was observed in 43% of patients, most commonly mediastinal (27%). When lymphadenopathy was present, it was more commonly mild (42%) or moderate (39%), rather than severe (20%). Organizing pneumonia lesions were presented with pleural effusions in 45% of patients (Fig. 5) . Pathological findings other than OP were uncommonly reported, with granulomas being the most common associated finding seen in 9% of patients.
Organizing pneumonia in patients with lung malignancy was significantly more often found with single or multiple discrete lesions (80%; 95% confidence interval [CI], 59%-93%) (Fig. 6 ) rather than a diffuse process when compared with patients with other malignancies (55%; 95% CI, 46%-64%; P = 0.025) ( Table 3 ). In contrast, a diffuse process was significantly more often seen with HSCT (59%; 95% CI, 39%-76%) (Fig. 7) rather than single or multiple discrete lesions when compared with patients who had not received HSCT (37%; 95% CI, 28%-46%; P = 0.038) ( Table 4) . Organizing pneumonia presenting in a peripheral location was also more frequently seen in patients with lung cancer (76%; 95% CI, 55%-91%) when compared with patients with other malignancies (38%; 95% CI, 29%-47%; P = 0.002). A trend of more air bronchograms was also found in OP in the HSCT group (41%; 95% CI, 24%-61%) when compared with patients without HSCT (23%; 95% CI, 16%-31%) (P = 0.060).
DISCUSSION
A wide range of lung parenchymal findings are commonly encountered on the CT imaging of oncologic patients, both incidentally during routine staging or during investigation of respiratory symptoms. Differential diagnosis for these findings includes tumor (primary or metastatic), infection, drug reactions, postradiation fibrosis, and OP. Organizing pneumonia cannot be diagnosed on the basis of clinical presentation and is generally a diagnosis of exclusion.
In this study of 151 oncologic patients, OP most commonly presented as a process with an ill-defined margin. The presence of an irregular border has been reported in various studies. In a study correlating CT appearances of OP with pathological findings in 17 patients who underwent surgical resection, Yang et al Previous studies have demonstrated that OP uncommonly presents in a central location. In a review of 45 cases of focal OP by Zhao et al, 1 OP never presented in a central location. Similarly, in a study of focal OP in 18 patients by Kohno et al, 9 all lesions were in a peripheral location. In our study, only 3% of the patients demonstrated central lesions, and OP was not found in a central location in any of the 25 patients with lung cancer. Our findings suggest, as have previous studies, that OP is highly unlikely to present as a central lesion without peripheral lung findings. Air bronchograms have been reported as a feature of OP in a number of studies 10, 11 but were only identified in 27% of cases in this study. Cavitation and necrosis, 2 features not typically associated with OP, were only identified in a very small number of cases (6% and 1%, respectively).
In all patients, a diffuse pattern was the most common presentation of OP; however, in patients with a history of lung cancer, OP most commonly presented as a single focal lesion (56%). In a population with lung cancer, the presence of a new solitary lesion is most concerning for recurrent or metastatic disease, and tissue biopsy is required to differentiate OP from recurrent tumor. In their study of 45 patients, Zhao et al 1 sought to determine CT features that could differentiate OP from lung carcinoma; however, they concluded that small OP lesions may resemble lung carcinoma.
The potential for a misdiagnosis of OP as a malignancy is well described in the literature. In an oncologic population, OP can occur as a complication of treatment, having been described after chemotherapy, radiation therapy, bone marrow, and solid organ transplant. In fact, pulmonary complications have been reported to occur in 40% to 60% of patients after HSCT. 12 In a review of 5340 post-HSCT patients with 49 cases of OP by Freudenberger et al, 13 cases of OP were found as early as 5 days posttransplant, with a median occurrence of between 3 and 4 months after HSCT. A review of CT appearances of 43 patients with OP revealed greater ground glass involvement (73% vs 56%) in post-HSCT patients and other immunocompromised patients than in immunocompetent patients. 10 This is in keeping with our study findings with GGOs observed in 62% of HSCT patients versus 51% in the nontransplant group. In our study, 59% of patients who underwent HSCT demonstrated a diffuse process of alveolar infiltration versus 37% of the nontransplant group. A diffuse pattern of alveolar infiltration in an immunosuppressed population generally suggests infection; however, if features of OP are demonstrated, this should be considered as an alternate diagnosis. Our study has a number of limitations. This was a retrospective study with potential for selection bias. In addition, given that OP can occur as a complication of various oncologic treatments, it would be interesting to correlate both the treatment and type of treatment received with the subsequent diagnosis of OP. This was outside the scope of the article because our goal was to describe the CT features of OP in this unique patient population; however, it could provide the basis for a further study. To our knowledge, this is the largest group of patients with OP evaluated in a radiology article to date; however, the small numbers in the different patients limit the significance of the results. Finally, the image acquisition was not uniform for all patients. Because of the retrospective nature of the study, 1.25-mm slice images were only available for review in 26 of 151 patients.
In conclusion, the diagnosis of OP can prove quite challenging in an oncologic population where CT findings can mimic recurrent or metastatic tumor. A high index of suspicion is required to avoid misdiagnosis especially in patients who are unresponsive to conventional therapy. Our study demonstrated that OP commonly presented as diffuse lesions in both central and peripheral locations in the oncologic patient. When compared with OP in other malignancies, OP in patients with lung cancer was significantly more likely to be associated with discrete lesions and in a peripheral location. In patients with HSCT, OP was significantly more often associated with a diffuse presentation when compared with patients without a history of HSCT. 
